Chifeng Donghui Pharmaceutical Co., Ltd. is located in the experimental zone for economic transformation and development of resource-based cities in Yuanbaoshan District, Chifeng City. The company was registered and established in September 2019, with a total investment of 130 million yuan and an area of 64.2 mu. Its design capacity is to produce 1000 tons of camphor sulfonic acid, 1000 uracil, and related by-products annually. It is one of the largest camphor sulfonic acid production enterprises in China,

acid production enterprises in China, and is a high-tech production enterprise dedicated to the production, sales,research, and development of camphor sulfonic acid,uracil, and related biochemical raw materials. Its products are mainly sold to Shandong, Hebei, Jiangsu, Zhejiang, Guangdong, and other places, As well as countries such as India, Japan, South Korea, Mexico, and the United States, the company has important applications in fields such as medicine, chemical engineering, and water treatment. Currently, the company has 65 employees and 11 technical personnel. Donghui Pharmaceutical has a group of experienced and mature technical personnel, with production technology at a leading level in the same industry, and occupies an important position in both domestic and international markets.